Compare Cipta Sarana Medika Tbk. (DKHH) vs Fore Kopi Indonesia Tbk. (FORE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cipta Sarana Medika Tbk. vs Fore Kopi Indonesia Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp63 (market cap 158.12B, 8.21M 24h volume), while Fore Kopi Indonesia Tbk. trades at Rp615 (market cap 5.44T, 1.89M 24h volume). The key difference: Fore Kopi Indonesia Tbk. is far larger — about 34.4× Cipta Sarana Medika Tbk.'s market cap, and Cipta Sarana Medika Tbk. is more actively traded (8.21M versus 1.89M). Which is the better fit depends on your goals.
| DKHH | FORE | |
|---|---|---|
Market Cap | 158.12B | 5.44T |
Volume | 8.21M | 1.89M |
Lot | 82.15K | 18.9K |
Turnover | 515.2M | 1.15B |
Average Price | 62.72 | 609.92 |
Value | 515.2M | 1.15B |
Indicative Equilibrium Price | 63 | 615 |
Indicative Equilibrium Volume | 1.33K | 1.29K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cipta Sarana Medika Tbk.
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →About Fore Kopi Indonesia Tbk.
PT Fore Kopi Indonesia Tbk (the Company) was established in Jakarta based on Notarial Deed No. 6 dated July 3, 2018 of Jose Dima Satria, S.H., M.Kn. The Company commenced its commercial operations in August 2018. The controlling shareholder of the Company is EVLab Fore Pte. Ltd., through its ownership in Fore Holdings Pte. Ltd.
Read more on FORE →
